Serum-integrated omics reveal the host response landscape for severe pediatric community-acquired pneumonia

Abstract

Objective Community-acquired pneumonia (CAP) is the primary cause of death for children under five years of age globally. Hence, it is essential to investigate new early biomarkers and potential mechanisms involved in disease severity. Methods Proteomics combined with metabolomics was performed to identify biomarkers suitable for early diagnosis of severe CAP. In the training cohort, proteomics and metabolomics were performed on serum samples obtained from 20 severe CAPs (S-CAPs), 15 non-severe CAPs (NS-CAPs) and 15 healthy controls (CONs). In the verification cohort, selected biomarkers and their combinations were validated using ELISA and metabolomics in an independent cohort of 129 subjects. Finally, a combined proteomics and metabolomics analysis was performed to understand the major pathological features and reasons for severity of CAP. Results The proteomic and metabolic signature was markedly different between S-CAPs, NS-CAPs and CONs. A new serum biomarker panel including 2 proteins [C-reactive protein (CRP), lipopolysaccharide (LBP)] and 3 metabolites [Fasciculol C, PE (14:0/16:1(19Z)), PS (20:0/22:6(4Z, 7Z, 10Z, 13Z, 16Z, 19Z))] was developed to identify CAP and to distinguish severe pneumonia. Pathway analysis of changes revealed activation of the cell death pathway, a dysregulated complement system, coagulation cascade and platelet function, and the inflammatory responses as contributors to tissue damage in children with CAP. Additionally, activation of glycolysis and higher levels of nucleotides led to imbalanced deoxyribonucleotide pools contributing to the development of severe CAP. Finally, dysregulated lipid metabolism was also identified as a potential pathological mechanism for severe progression of CAP. Conclusion The integrated analysis of the proteome and metabolome might open up new ways in diagnosing and uncovering the complexity of severity of CAP.

Genomic data integration tutorial, a plant case study

“…). Hence, it has been used in medicine to predict diseases evolution from cohorts [ 30 ], or in agronomy to predict yield (grain) production in cereals [ 31 ].…”

Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy

“…The Th1/Th2 34-plex human ProcartaPlex kit (Thermo Fisher Scientific) was used to measure plasma cytokine levels and performed as described by the manufacturer’s instructions and previous reports. 29 , 47 …”

Deep learning enhanced the diagnostic merit of serum glycome for multiple cancers

“… 29 , 30 , 31 , 32 Recent studies on the relationship between glycosylation and cancer diseases have utilized machine learning models to assist in the classification between patients with cancer and healthy individuals, as well as to screen for relevant glycan biomarkers. 33 Since the training data are the knowledge source of the machine learning models, it could be difficult to build models with decent performance for groups with small sample size. On the other hand, differences among datasets could potentially form challenges in maintaining comparable performance of a model trained on one cohort when applied to another cohort.…”